Gene Symbol | Gene ID | Gene Info |
---|---|---|
EPAS1
|
ENSG00000116016.9 | endothelial PAS domain protein 1 |
BCL3
|
ENSG00000069399.8 | BCL3 transcription coactivator |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_45256342_45256683 | BCL3 | 1934 | 0.204451 | -0.86 | 2.9e-03 | Click! |
chr19_45250951_45251364 | BCL3 | 647 | 0.567020 | -0.85 | 3.4e-03 | Click! |
chr19_45258275_45258481 | BCL3 | 3800 | 0.132638 | -0.85 | 3.6e-03 | Click! |
chr19_45257252_45257704 | BCL3 | 2900 | 0.152038 | -0.82 | 6.2e-03 | Click! |
chr19_45256798_45256993 | BCL3 | 2317 | 0.176735 | -0.81 | 7.6e-03 | Click! |
chr2_46524572_46524838 | EPAS1 | 164 | 0.971380 | -0.61 | 8.4e-02 | Click! |
chr2_46523894_46524304 | EPAS1 | 352 | 0.921263 | -0.60 | 8.4e-02 | Click! |
chr2_46547328_46547516 | EPAS1 | 22881 | 0.232308 | 0.60 | 8.5e-02 | Click! |
chr2_46497095_46497294 | EPAS1 | 26553 | 0.225931 | 0.59 | 9.7e-02 | Click! |
chr2_46547628_46547783 | EPAS1 | 23164 | 0.231436 | 0.57 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_12309017_12309498 | 2.42 |
MICALCL |
MICAL C-terminal like |
810 |
0.62 |
chr1_32044138_32044454 | 1.76 |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
2157 |
0.23 |
chr19_3606102_3607092 | 1.62 |
TBXA2R |
thromboxane A2 receptor |
61 |
0.89 |
chr7_112725821_112726406 | 1.58 |
GPR85 |
G protein-coupled receptor 85 |
280 |
0.92 |
chr16_51184635_51185066 | 1.48 |
SALL1 |
spalt-like transcription factor 1 |
302 |
0.89 |
chrX_107179250_107179655 | 1.43 |
RP6-191P20.4 |
|
242 |
0.93 |
chr11_118478413_118479735 | 1.41 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
716 |
0.54 |
chr9_18474095_18474958 | 1.41 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr3_133748166_133748506 | 1.40 |
SLCO2A1 |
solute carrier organic anion transporter family, member 2A1 |
422 |
0.9 |
chr19_10120368_10120847 | 1.39 |
COL5A3 |
collagen, type V, alpha 3 |
540 |
0.61 |
chr1_31380173_31380807 | 1.27 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr7_94025506_94025990 | 1.27 |
COL1A2 |
collagen, type I, alpha 2 |
1875 |
0.46 |
chr19_19383372_19383777 | 1.24 |
TM6SF2 |
transmembrane 6 superfamily member 2 |
523 |
0.66 |
chr17_36609355_36609985 | 1.23 |
ENSG00000260833 |
. |
982 |
0.5 |
chr18_32290517_32290846 | 1.23 |
DTNA |
dystrobrevin, alpha |
420 |
0.9 |
chr2_190041307_190041749 | 1.21 |
COL5A2 |
collagen, type V, alpha 2 |
3077 |
0.31 |
chr1_75138923_75139762 | 1.21 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr5_136833711_136834156 | 1.20 |
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
314 |
0.93 |
chr1_112532383_112532987 | 1.20 |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
908 |
0.69 |
chr15_37391316_37391907 | 1.19 |
MEIS2 |
Meis homeobox 2 |
14 |
0.54 |
chr7_132260669_132261651 | 1.13 |
PLXNA4 |
plexin A4 |
69 |
0.98 |
chr9_130639317_130639975 | 1.13 |
AK1 |
adenylate kinase 1 |
376 |
0.71 |
chr1_205648469_205649627 | 1.13 |
SLC45A3 |
solute carrier family 45, member 3 |
539 |
0.74 |
chr17_59476045_59476898 | 1.08 |
RP11-332H18.4 |
|
260 |
0.74 |
chr6_163817634_163818149 | 1.07 |
QKI |
QKI, KH domain containing, RNA binding |
17784 |
0.29 |
chr6_166401265_166401649 | 1.07 |
ENSG00000252196 |
. |
45628 |
0.17 |
chr12_86229562_86230264 | 1.05 |
RASSF9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
435 |
0.89 |
chr11_79151624_79152198 | 1.05 |
TENM4 |
teneurin transmembrane protein 4 |
216 |
0.95 |
chr19_41195138_41195302 | 1.02 |
NUMBL |
numb homolog (Drosophila)-like |
277 |
0.86 |
chr1_156647773_156647946 | 1.01 |
NES |
nestin |
670 |
0.5 |
chr13_58203621_58204059 | 1.00 |
PCDH17 |
protocadherin 17 |
2815 |
0.43 |
chr4_24472696_24473642 | 1.00 |
ENSG00000265001 |
. |
41714 |
0.15 |
chr8_69242814_69243988 | 0.98 |
C8orf34 |
chromosome 8 open reading frame 34 |
56 |
0.82 |
chr12_115889903_115890336 | 0.98 |
RP11-116D17.1 |
HCG2038717; Uncharacterized protein |
89302 |
0.1 |
chr16_88219567_88219948 | 0.98 |
BANP |
BTG3 associated nuclear protein |
216133 |
0.02 |
chr8_49831086_49831370 | 0.97 |
SNAI2 |
snail family zinc finger 2 |
2760 |
0.41 |
chr12_72665374_72665945 | 0.96 |
ENSG00000236333 |
. |
112 |
0.93 |
chr11_132953015_132953394 | 0.95 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
139541 |
0.05 |
chr18_53089837_53090372 | 0.95 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr19_16179581_16179939 | 0.95 |
TPM4 |
tropomyosin 4 |
1250 |
0.44 |
chr17_31255969_31256206 | 0.95 |
TMEM98 |
transmembrane protein 98 |
859 |
0.62 |
chr22_36232996_36233711 | 0.94 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2912 |
0.37 |
chr2_105458782_105459564 | 0.94 |
LINC01158 |
long intergenic non-protein coding RNA 1158 |
8738 |
0.14 |
chr10_118033216_118033536 | 0.93 |
GFRA1 |
GDNF family receptor alpha 1 |
397 |
0.9 |
chr6_13733598_13733910 | 0.92 |
RANBP9 |
RAN binding protein 9 |
21958 |
0.19 |
chr2_206549618_206550045 | 0.92 |
NRP2 |
neuropilin 2 |
1816 |
0.48 |
chr13_98796347_98796640 | 0.92 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
759 |
0.68 |
chr16_2077067_2078193 | 0.92 |
SLC9A3R2 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
701 |
0.35 |
chr8_145910346_145910740 | 0.91 |
ARHGAP39 |
Rho GTPase activating protein 39 |
651 |
0.64 |
chr1_29563184_29564088 | 0.90 |
PTPRU |
protein tyrosine phosphatase, receptor type, U |
485 |
0.75 |
chr17_20491916_20492779 | 0.89 |
CDRT15L2 |
CMT1A duplicated region transcript 15-like 2 |
9310 |
0.21 |
chr11_57406082_57406969 | 0.88 |
AP000662.4 |
|
676 |
0.5 |
chr8_89340038_89340774 | 0.88 |
MMP16 |
matrix metallopeptidase 16 (membrane-inserted) |
152 |
0.73 |
chr20_9049623_9049963 | 0.87 |
PLCB4 |
phospholipase C, beta 4 |
45 |
0.98 |
chr17_80339190_80339423 | 0.85 |
UTS2R |
urotensin 2 receptor |
7153 |
0.1 |
chr11_118492062_118492969 | 0.85 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
14157 |
0.11 |
chr1_153584096_153584410 | 0.84 |
S100A16 |
S100 calcium binding protein A16 |
1306 |
0.22 |
chr1_151913762_151913913 | 0.84 |
THEM4 |
thioesterase superfamily member 4 |
31553 |
0.11 |
chr1_33219625_33220407 | 0.84 |
KIAA1522 |
KIAA1522 |
394 |
0.82 |
chr12_118626563_118627015 | 0.84 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr5_115790032_115790655 | 0.84 |
CTB-118N6.3 |
|
4917 |
0.26 |
chr12_3069053_3070004 | 0.84 |
TEAD4 |
TEA domain family member 4 |
445 |
0.77 |
chr6_105388737_105389249 | 0.83 |
LIN28B |
lin-28 homolog B (C. elegans) |
15930 |
0.23 |
chr2_218843405_218844030 | 0.82 |
TNS1 |
tensin 1 |
60 |
0.79 |
chr10_132588844_132588995 | 0.81 |
ENSG00000264803 |
. |
172012 |
0.04 |
chr18_52495652_52496658 | 0.81 |
RAB27B |
RAB27B, member RAS oncogene family |
725 |
0.77 |
chr8_42063953_42065062 | 0.81 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr16_10922458_10922819 | 0.81 |
TVP23A |
trans-golgi network vesicle protein 23 homolog A (S. cerevisiae) |
9996 |
0.18 |
chr1_45308302_45308945 | 0.80 |
PTCH2 |
patched 2 |
7 |
0.95 |
chr16_85268847_85269227 | 0.80 |
CTC-786C10.1 |
|
64155 |
0.11 |
chr22_29075189_29075804 | 0.78 |
TTC28 |
tetratricopeptide repeat domain 28 |
357 |
0.87 |
chr5_92918344_92919004 | 0.78 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
369 |
0.84 |
chr6_170461369_170461520 | 0.78 |
RP11-302L19.1 |
|
16297 |
0.25 |
chr2_158120680_158120854 | 0.78 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
6657 |
0.24 |
chr3_112931196_112931871 | 0.78 |
BOC |
BOC cell adhesion associated, oncogene regulated |
124 |
0.97 |
chr3_147140468_147140953 | 0.78 |
ZIC1 |
Zic family member 1 |
13539 |
0.19 |
chr1_86042054_86042529 | 0.77 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
1642 |
0.36 |
chr3_36805291_36805678 | 0.77 |
DCLK3 |
doublecortin-like kinase 3 |
24132 |
0.23 |
chr8_77594904_77595092 | 0.76 |
ZFHX4 |
zinc finger homeobox 4 |
236 |
0.67 |
chr2_187559481_187559668 | 0.76 |
AC017101.10 |
|
440 |
0.69 |
chr17_36621277_36621585 | 0.76 |
ARHGAP23 |
Rho GTPase activating protein 23 |
6749 |
0.17 |
chr7_19155713_19156221 | 0.75 |
TWIST1 |
twist family bHLH transcription factor 1 |
1328 |
0.36 |
chr13_24145710_24146057 | 0.75 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1080 |
0.66 |
chr14_42076336_42076756 | 0.75 |
LRFN5 |
leucine rich repeat and fibronectin type III domain containing 5 |
227 |
0.95 |
chr14_86000741_86001075 | 0.74 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
4336 |
0.28 |
chr7_87257054_87258255 | 0.74 |
RUNDC3B |
RUN domain containing 3B |
75 |
0.97 |
chr10_33621519_33621932 | 0.73 |
NRP1 |
neuropilin 1 |
1585 |
0.49 |
chr2_11272894_11273725 | 0.73 |
C2orf50 |
chromosome 2 open reading frame 50 |
54 |
0.98 |
chr17_47077080_47077320 | 0.73 |
IGF2BP1 |
insulin-like growth factor 2 mRNA binding protein 1 |
2092 |
0.16 |
chr19_13137554_13137705 | 0.73 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1818 |
0.2 |
chr18_6729547_6730123 | 0.73 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr9_129884150_129884930 | 0.71 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr4_158143046_158143598 | 0.71 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
504 |
0.84 |
chr16_29231357_29231508 | 0.71 |
RP11-231C14.6 |
|
92239 |
0.06 |
chr6_41437651_41438276 | 0.71 |
RP11-328M4.2 |
|
75849 |
0.08 |
chr18_5629293_5629838 | 0.71 |
ENSG00000252432 |
. |
32484 |
0.15 |
chr1_44513542_44514157 | 0.70 |
SLC6A9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
16715 |
0.14 |
chr18_75239336_75239487 | 0.70 |
ENSG00000199392 |
. |
95766 |
0.09 |
chr3_37903958_37904647 | 0.70 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
637 |
0.58 |
chr4_177711668_177712016 | 0.70 |
VEGFC |
vascular endothelial growth factor C |
2039 |
0.48 |
chr11_46300696_46300847 | 0.70 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
1543 |
0.37 |
chr8_142010048_142010787 | 0.69 |
PTK2 |
protein tyrosine kinase 2 |
619 |
0.8 |
chr16_55542879_55544136 | 0.69 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
597 |
0.77 |
chr18_52763849_52764148 | 0.69 |
ENSG00000252437 |
. |
49878 |
0.16 |
chr3_116163640_116163792 | 0.69 |
LSAMP |
limbic system-associated membrane protein |
114 |
0.98 |
chr18_31157392_31158104 | 0.68 |
ASXL3 |
additional sex combs like 3 (Drosophila) |
848 |
0.76 |
chr22_24640119_24640309 | 0.68 |
GGT5 |
gamma-glutamyltransferase 5 |
813 |
0.59 |
chr9_71939475_71940274 | 0.68 |
FAM189A2 |
family with sequence similarity 189, member A2 |
386 |
0.91 |
chr6_82854353_82854866 | 0.68 |
ENSG00000223044 |
. |
65548 |
0.14 |
chr1_214387403_214387935 | 0.67 |
SMYD2 |
SET and MYND domain containing 2 |
66907 |
0.13 |
chr3_129323468_129324020 | 0.67 |
PLXND1 |
plexin D1 |
1917 |
0.3 |
chr13_110960499_110960922 | 0.67 |
COL4A2 |
collagen, type IV, alpha 2 |
1096 |
0.42 |
chr12_3308931_3310293 | 0.67 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr11_48085341_48085729 | 0.66 |
ENSG00000263693 |
. |
32799 |
0.16 |
chr6_75914274_75914680 | 0.66 |
COL12A1 |
collagen, type XII, alpha 1 |
1061 |
0.59 |
chr12_115341376_115341564 | 0.66 |
ENSG00000252459 |
. |
165961 |
0.04 |
chr7_29763365_29763528 | 0.65 |
ENSG00000212024 |
. |
43002 |
0.15 |
chr2_167232459_167233133 | 0.65 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
293 |
0.93 |
chr15_69168095_69168250 | 0.65 |
SPESP1 |
sperm equatorial segment protein 1 |
54667 |
0.11 |
chr5_58592476_58593460 | 0.65 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
21023 |
0.29 |
chr7_129933276_129933885 | 0.64 |
CPA4 |
carboxypeptidase A4 |
461 |
0.76 |
chr4_16900069_16900243 | 0.64 |
LDB2 |
LIM domain binding 2 |
29 |
0.99 |
chr9_16869370_16869521 | 0.64 |
BNC2 |
basonuclin 2 |
1259 |
0.62 |
chr1_33167424_33167698 | 0.64 |
SYNC |
syncoilin, intermediate filament protein |
800 |
0.55 |
chr5_88081093_88081351 | 0.64 |
MEF2C |
myocyte enhancer factor 2C |
38383 |
0.18 |
chr19_6740138_6741070 | 0.63 |
TRIP10 |
thyroid hormone receptor interactor 10 |
325 |
0.81 |
chr8_122653917_122654172 | 0.63 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
368 |
0.53 |
chr12_79258716_79258905 | 0.63 |
SYT1 |
synaptotagmin I |
218 |
0.97 |
chr13_101240923_101241511 | 0.63 |
GGACT |
gamma-glutamylamine cyclotransferase |
232 |
0.94 |
chr2_45182324_45182565 | 0.63 |
SIX3-AS1 |
SIX3 antisense RNA 1 |
13432 |
0.21 |
chr11_44899424_44899838 | 0.62 |
TSPAN18 |
tetraspanin 18 |
18477 |
0.25 |
chr19_2524704_2524855 | 0.62 |
ENSG00000252962 |
. |
21640 |
0.14 |
chr5_133846660_133846957 | 0.62 |
ENSG00000240250 |
. |
6693 |
0.16 |
chr3_8561489_8561767 | 0.62 |
LMCD1 |
LIM and cysteine-rich domains 1 |
17241 |
0.2 |
chr2_216297601_216297993 | 0.62 |
FN1 |
fibronectin 1 |
2993 |
0.27 |
chr13_34217183_34217463 | 0.61 |
RFC3 |
replication factor C (activator 1) 3, 38kDa |
174863 |
0.03 |
chr17_7257720_7257871 | 0.61 |
RP11-542C16.1 |
|
468 |
0.42 |
chr9_68810140_68810583 | 0.61 |
ENSG00000266021 |
. |
187123 |
0.03 |
chr12_116819979_116820276 | 0.61 |
ENSG00000264037 |
. |
45996 |
0.17 |
chr22_37822529_37822680 | 0.61 |
RP1-63G5.5 |
|
876 |
0.37 |
chr11_63639243_63639445 | 0.61 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
2596 |
0.2 |
chr1_19973947_19974889 | 0.60 |
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
314 |
0.87 |
chrX_70366066_70366529 | 0.60 |
NLGN3 |
neuroligin 3 |
1585 |
0.25 |
chr4_25309118_25309269 | 0.60 |
ZCCHC4 |
zinc finger, CCHC domain containing 4 |
5215 |
0.25 |
chr12_108991532_108991806 | 0.60 |
TMEM119 |
transmembrane protein 119 |
115 |
0.95 |
chr7_134451835_134452118 | 0.60 |
CALD1 |
caldesmon 1 |
12188 |
0.28 |
chr15_39876000_39876186 | 0.60 |
THBS1 |
thrombospondin 1 |
2799 |
0.26 |
chr1_21977639_21978366 | 0.60 |
RAP1GAP |
RAP1 GTPase activating protein |
327 |
0.9 |
chr5_95309703_95309854 | 0.60 |
ELL2 |
elongation factor, RNA polymerase II, 2 |
12003 |
0.19 |
chr5_88238184_88238467 | 0.59 |
MEF2C-AS1 |
MEF2C antisense RNA 1 |
579 |
0.83 |
chr1_118679267_118679564 | 0.59 |
SPAG17 |
sperm associated antigen 17 |
48431 |
0.18 |
chr19_434282_434433 | 0.59 |
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
2177 |
0.2 |
chr10_13748513_13748974 | 0.59 |
ENSG00000222235 |
. |
1765 |
0.25 |
chr14_85998039_85998552 | 0.59 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
1723 |
0.42 |
chrX_71933533_71934701 | 0.59 |
PHKA1 |
phosphorylase kinase, alpha 1 (muscle) |
11 |
0.97 |
chr9_16626345_16626809 | 0.59 |
RP11-62F24.1 |
|
903 |
0.71 |
chr12_91574306_91575101 | 0.59 |
DCN |
decorin |
50 |
0.99 |
chr20_50177164_50177436 | 0.57 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
1868 |
0.48 |
chr7_55088250_55088401 | 0.57 |
EGFR |
epidermal growth factor receptor |
1514 |
0.55 |
chr1_213500802_213501077 | 0.57 |
RPS6KC1 |
ribosomal protein S6 kinase, 52kDa, polypeptide 1 |
276335 |
0.01 |
chr12_26277242_26278053 | 0.57 |
BHLHE41 |
basic helix-loop-helix family, member e41 |
413 |
0.76 |
chr11_7598410_7598701 | 0.57 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
284 |
0.91 |
chr10_63698495_63698899 | 0.56 |
ENSG00000221272 |
. |
11920 |
0.25 |
chr5_15499822_15500142 | 0.56 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
323 |
0.94 |
chr4_150999769_151000790 | 0.56 |
DCLK2 |
doublecortin-like kinase 2 |
99 |
0.98 |
chr15_88799602_88799984 | 0.56 |
NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
132 |
0.98 |
chr1_164529222_164529675 | 0.56 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
388 |
0.91 |
chr2_172963527_172963843 | 0.56 |
DLX2 |
distal-less homeobox 2 |
3943 |
0.24 |
chr5_155754238_155754771 | 0.56 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
737 |
0.81 |
chr4_129491193_129491344 | 0.55 |
ENSG00000238802 |
. |
185913 |
0.03 |
chr4_159093168_159093728 | 0.55 |
RP11-597D13.9 |
|
281 |
0.64 |
chr19_56988243_56988602 | 0.55 |
ZNF667 |
zinc finger protein 667 |
65 |
0.96 |
chr8_58660875_58661197 | 0.55 |
ENSG00000252057 |
. |
191892 |
0.03 |
chr2_11622794_11623343 | 0.55 |
E2F6 |
E2F transcription factor 6 |
16793 |
0.13 |
chr4_183369422_183369983 | 0.55 |
TENM3 |
teneurin transmembrane protein 3 |
450 |
0.89 |
chr1_200320777_200320954 | 0.55 |
ZNF281 |
zinc finger protein 281 |
58255 |
0.16 |
chr2_36923854_36924159 | 0.54 |
VIT |
vitrin |
3 |
0.98 |
chr9_10612773_10613124 | 0.54 |
PTPRD |
protein tyrosine phosphatase, receptor type, D |
225 |
0.97 |
chr3_32021796_32022649 | 0.54 |
OSBPL10 |
oxysterol binding protein-like 10 |
570 |
0.63 |
chr7_41740779_41741576 | 0.54 |
INHBA |
inhibin, beta A |
970 |
0.56 |
chr14_85995700_85996361 | 0.54 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
458 |
0.75 |
chr2_85020186_85020337 | 0.54 |
DUXAP1 |
double homeobox A pseudogene 1 |
42368 |
0.16 |
chr2_14772882_14773213 | 0.54 |
FAM84A |
family with sequence similarity 84, member A |
223 |
0.94 |
chr11_8891865_8892474 | 0.54 |
ST5 |
suppression of tumorigenicity 5 |
295 |
0.85 |
chr6_85482826_85483217 | 0.54 |
TBX18 |
T-box 18 |
8784 |
0.3 |
chr4_168154960_168155824 | 0.54 |
SPOCK3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
25 |
0.99 |
chr9_34651822_34652525 | 0.54 |
IL11RA |
interleukin 11 receptor, alpha |
16 |
0.94 |
chr19_1524467_1524618 | 0.53 |
PLK5 |
polo-like kinase 5 |
416 |
0.64 |
chr8_22023419_22024083 | 0.53 |
BMP1 |
bone morphogenetic protein 1 |
951 |
0.4 |
chr10_72433024_72433359 | 0.53 |
ADAMTS14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
632 |
0.79 |
chr17_70461490_70461782 | 0.53 |
ENSG00000200783 |
. |
198655 |
0.03 |
chr20_9049976_9050220 | 0.53 |
PLCB4 |
phospholipase C, beta 4 |
350 |
0.89 |
chr17_31255277_31255844 | 0.53 |
TMEM98 |
transmembrane protein 98 |
332 |
0.89 |
chr19_13135354_13135619 | 0.53 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
45 |
0.95 |
chr20_36040630_36041025 | 0.53 |
SRC |
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
28274 |
0.21 |
chr9_69146753_69147145 | 0.53 |
PGM5P2 |
phosphoglucomutase 5 pseudogene 2 |
545 |
0.82 |
chr5_88168642_88169029 | 0.53 |
MEF2C |
myocyte enhancer factor 2C |
4959 |
0.27 |
chr10_121013259_121013542 | 0.53 |
ENSG00000242853 |
. |
41031 |
0.11 |
chr16_86542600_86543872 | 0.52 |
FOXF1 |
forkhead box F1 |
897 |
0.62 |
chr11_112125884_112126163 | 0.52 |
AP002884.2 |
LOC100132686 protein; Uncharacterized protein |
4965 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.4 | 1.1 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 1.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.4 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.6 | GO:0021508 | floor plate formation(GO:0021508) |
0.2 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 1.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.6 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.2 | 0.5 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.2 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.5 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 0.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.6 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.2 | GO:0050923 | Roundabout signaling pathway(GO:0035385) regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 0.5 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.6 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0060083 | urinary bladder smooth muscle contraction(GO:0014832) smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 1.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 1.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.4 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 1.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 2.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 2.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.4 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.4 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) mesenchymal to epithelial transition(GO:0060231) renal vesicle morphogenesis(GO:0072077) metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.3 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.5 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0010659 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 1.0 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 1.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.7 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.1 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.4 | GO:0034331 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.3 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.8 | GO:0035411 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 1.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.1 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.6 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0045933 | positive regulation of muscle contraction(GO:0045933) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.5 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.3 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.9 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.3 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.1 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.1 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.2 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.6 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.0 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.6 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:1901888 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) regulation of adherens junction organization(GO:1903391) |
0.0 | 0.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.7 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.3 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.0 | 0.1 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.0 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.4 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 2.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.4 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) vein smooth muscle contraction(GO:0014826) regulation of cell maturation(GO:1903429) |
0.0 | 0.1 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0060296 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 1.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 3.3 | GO:0007411 | axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
0.0 | 0.1 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 1.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.6 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.4 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 0.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 1.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.2 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.0 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.0 | 0.0 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.0 | GO:0015837 | amine transport(GO:0015837) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.4 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.0 | GO:0031340 | regulation of vesicle fusion(GO:0031338) positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.0 | GO:0010657 | muscle cell apoptotic process(GO:0010657) regulation of muscle cell apoptotic process(GO:0010660) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.0 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0006837 | serotonin secretion(GO:0001820) serotonin transport(GO:0006837) |
0.0 | 0.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 2.1 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.9 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 0.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 1.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 1.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 14.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 2.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 3.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 2.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 1.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.0 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 3.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.5 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 2.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 2.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.5 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 7.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 1.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 2.2 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 1.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0048406 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 1.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.0 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 1.0 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.0 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 3.1 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 3.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 7.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 6.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 4.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 8.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |